Is cognitive impairment associated with antipsychotic dose and anticholinergic equivalent loads in first-episode psychosis?


Por: Ballesteros, A, Sanchez-Torres, AM, Lopez-Ilundain, JM, Cabrera, B, Lobo, A, Gonzalez-Pinto, AM, Diaz-Caneja, C, Corripio, I, Vieta, E, la Serna, E, Bobes, J, Usall, J, Contreras, F, Lorente-Omenaca, R, Mezquida, G, Bernardo, M, Cuesta, MJ

Publicada: 1 oct 2018
Resumen:
Background. Cognitive deficits are a core feature of early stages in schizophrenia. However, the extent to which antipsychotic (AP) have a deleterious effect on cognitive performance remains under debate. We aim to investigate whether anticholinergic loadings and dose of AP drugs in first episode of psychosis (FEP) in advanced phase of remission are associated with cognitive impairment and the differences between premorbid intellectual quotient (IQ) subgroups. Methods. Two hundred and sixty-six patients participated. The primary outcomes were cognitive dimensions, dopaminergic/anticholinergic load of AP [in chlorpromazine equivalents (Eq-CPZ) and the Anticholinergic Risk Scale (ARS), respectively]. Results. Impairments in processing speed, verbal memory and global cognition were significantly associated with high Eq-CPZ and verbal impairment with high ARS score. Moreover, this effect was higher in the low IQ subgroup. Conclusions. Clinicians should be aware of the potential cognitive impairment associated with AP in advanced remission FEP, particularly in lower premorbid IQ patients.

Filiaciones:
Ballesteros, A:
 Estella Mental Hlth Ctr, Direcc Salud Mental, Pamplona, Navarra, Spain

 Navarra Inst Hlth Res, IdiSNA, Pamplona, Spain

Sanchez-Torres, AM:
 Navarra Inst Hlth Res, IdiSNA, Pamplona, Spain

 Complejo Hosp Navarra, Dept Psychiat, Pamplona, Spain

Lopez-Ilundain, JM:
 Navarra Inst Hlth Res, IdiSNA, Pamplona, Spain

 Complejo Hosp Navarra, Dept Psychiat, Pamplona, Spain

Cabrera, B:
 Hosp Clin Barcelona, Neurosci Inst, Schizophrenia Unit, Barcelona Clin, Barcelona, Spain

 Network Ctr Biomed Res Mental Hlth CIBERSAM, Madrid, Spain

Lobo, A:
 Univ Zaragoza, Aragon Inst Hlth Res IIS Aragon, Dept Med & Psychiat, Zaragoza, Spain

Gonzalez-Pinto, AM:
 Network Ctr Biomed Res Mental Hlth CIBERSAM, Madrid, Spain

 Univ Hosp, OSI Araba, BIOARABA Hlth Res Inst, Vitoria, Spain

 Univ Basque Country, Vitoria, Spain

Diaz-Caneja, C:
 Network Ctr Biomed Res Mental Hlth CIBERSAM, Madrid, Spain

 Univ Complutense, Univ Gregorio Maranon, Sch Med, Hosp Gen,IiSGM,Dept Child & Adolescent Psychiat, Madrid, Spain

Corripio, I:
 Network Ctr Biomed Res Mental Hlth CIBERSAM, Madrid, Spain

 UAB, Hosp Santa Creu & Sant Pau, Dept Psychiat, Barcelona, Spain

Vieta, E:
 Network Ctr Biomed Res Mental Hlth CIBERSAM, Madrid, Spain

 Hosp Clin Barcelona, Clin Inst Neurosci, Dept Psychiat & Psychol, Catalonia, Spain

 August Pi i Sunyer Inst Biomed Res IDIBAPS, Barcelona, Catalonia, Spain

 Univ Barcelona, Dept Psychiat & Clin Psychol, Barcelona, Catalonia, Spain

 Univ Barcelona, IDIBAPS, Dept Psychiat & Clin Psychobiol, Barcelona, Spain

la Serna, E:
 Network Ctr Biomed Res Mental Hlth CIBERSAM, Madrid, Spain

 Univ Barcelona, Hosp Clin Barcelona, Inst Clin Neurosci,Dept Med,2014SGR489, IDIBAPS,Child & Adolescent Psychiat & Psychol Dep, Barcelona, Spain

Bobes, J:
 Network Ctr Biomed Res Mental Hlth CIBERSAM, Madrid, Spain

 Univ Oviedo, Psychiat Dept, Oviedo, Spain

 INEUROPA, Inst Neurosci Principal Asturias, Oviedo, Spain

Usall, J:
 Network Ctr Biomed Res Mental Hlth CIBERSAM, Madrid, Spain

 Parc Sanitari St Joan Deu, Barcelona, Spain

Contreras, F:
 Network Ctr Biomed Res Mental Hlth CIBERSAM, Madrid, Spain

 Bellvitge Univ Hospital, IDIBELL, Psychiat Dept, Lhospitalet De Llobregat, Spain

 Univ Barcelona, Sch Med, Dept Clin Sci, Barcelona, Spain

Lorente-Omenaca, R:
 Navarra Inst Hlth Res, IdiSNA, Pamplona, Spain

 Complejo Hosp Navarra, Dept Psychiat, Pamplona, Spain

Mezquida, G:
 Hosp Clin Barcelona, Neurosci Inst, Schizophrenia Unit, Barcelona Clin, Barcelona, Spain

 Network Ctr Biomed Res Mental Hlth CIBERSAM, Madrid, Spain

Bernardo, M:
 Hosp Clin Barcelona, Neurosci Inst, Schizophrenia Unit, Barcelona Clin, Barcelona, Spain

 Network Ctr Biomed Res Mental Hlth CIBERSAM, Madrid, Spain

 Univ Barcelona, IDIBAPS, Dept Psychiat & Clin Psychobiol, Barcelona, Spain

Cuesta, MJ:
 Navarra Inst Hlth Res, IdiSNA, Pamplona, Spain

 Complejo Hosp Navarra, Dept Psychiat, Pamplona, Spain

Univ Gregorio Maranon, Hosp Gen, Dept Child & Adolescent Psychiat, IiSGM, Madrid, Spain.
Inst Invest Sanitaria Aragon IIS Aragon, Hosp Clin Univ, Dept Psychiat, Zaragoza, Spain.
Inst Invest Sanitaria Aragon IIS Aragon, Quiron Hosp, Zaragoza, Spain.
Valencia Clin Hosp, INCLIVA, Episode Psychiat Unit 1, Valencia, Spain.
UAB, Hosp Mar Med Res Inst IMIM, Barcelona, Spain.
Univ Basque Country, UPV EHU, Biocruces Hlth Res Inst, Dept Neurosci, Baracaldo, Spain.
Hosp 12 Octubre i 12, Inst Invest, Madrid, Spain.
St Joan Deu Res Fdn, Barcelona, Spain.
Univ Barcelona, Fac Psychol, Barcelona, Spain.
Hosp St Joan Deu, Barcelona, Spain.
FIDMAG Hermanas Hosp Res Fdn, Barcelona, Spain.
Neurosci Res Australia, Sydney, NSW, Australia.
Univ New South Wales, Australia Sch Med Sci, Sydney, NSW, Australia.
Australia ARC Ctr Excellence Cognit & Disorders, Sydney, NSW, Australia.
Univ Alcala De Henares, Hosp Univ Ramon & Cajal, IRYCIS, Dept Psychiat, Madrid, Spain.
La Fe Univ & Polytech Hosp, Serv Psychiat, Valencia, Spain.
ISSN: 00332917





PSYCHOLOGICAL MEDICINE
Editorial
CAMBRIDGE UNIV PRESS, 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA, Estados Unidos America
Tipo de documento: Article
Volumen: 48 Número: 13
Páginas: 2247-2256
WOS Id: 000443816200015
ID de PubMed: 29331153

MÉTRICAS